AstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis

Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs.

Leave a Reply

Your email address will not be published. Required fields are marked *